Results 291 to 300 of about 43,089 (386)

Circulating Immune Cell Signature Analysis in HFpEF Across Species. [PDF]

Circ Res
Kneuer JM, Müller M, Erbe S, Kokot KE, Rosch S, Müller-Kozarez I, Schröder SC, Maeder C, Heitkamp SF, Gaul S, von Haehling S, Tönjes A, Blüher M, Lurz P, Wachter R, Klinke A, Laufs U, Boeckel JN.   +17 more
europepmc   +1 more source

Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE‐TR registry

European Journal of Heart Failure, EarlyView.
Aetiological phenotypes of secondary tricuspid regurgitation. AF, atrial fibrillation; HFpE, heart failure with preserved ejection fraction; CARE‐TR, Consecutive pAtients with seveRE Tricuspid Regurgitation evaluated in Heart Failure and Valve Clinics; HF, heart failure; HFmrEF, heart failure with mildly reduced ejection fraction; HFrEF, heart failure ...
Laura Lupi, Elena Antonioli, Angelica Praderio, Alessandro Villaschi, Elisa Soranzo, Nicola Saccani, Kamil Stankowski, Daniele Cocianni, Beniamino Pagliaro, Valeria Magni, Marco Loffi, Daniela Tomasoni, Matteo Pagnesi, Antonio Mangieri, Davide Stolfo, Gianfranco Sinagra, Marianna Adamo, Marco Metra   +17 more
wiley   +1 more source

Does HFpEF Exist? A Comment on "The Concept of 'Heart Failure with Preserved Ejection Fraction': Time for a Critical Reappraisal" (Rev Cardiovasc Med. 2023;24(7):202). [PDF]

Rev Cardiovasc Med
Bellicini MG.
europepmc   +1 more source

Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
ABSTRACT Aims Anaemia is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and associated with poor clinical outcomes. While renin–angiotensin system blockers reduce haemoglobin, little is known about the effect of mineralocorticoid receptor antagonists on haemoglobin and in patients with anaemia.
Misato Chimura, Mingming Yang, Alasdair D. Henderson, Pardeep S. Jhund, Kieran F. Docherty, Brian L. Claggett, Akshay S. Desai, Gerasimos Filippatos, Grzegorz Gajos, Katharina Mueller, Andrea Glasauer, Katja Rohwedder, Prabhakar Viswanathan, Carolyn S.P. Lam, Naoki Sato, Michele Senni, Adriaan A. Voors, Faiez Zannad, Mehmet B. Yilmaz, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V. McMurray, on behalf of the FINEARTS‐HF Committees and Investigators   +23 more
wiley   +1 more source

Comorbidities and incidence of heart failure with preserved ejection fraction: a systematic review and meta-analysis of cohort studies. [PDF]

BMJ Open
Li L, Li Z, Xu P, Huang L, Peng X, Yue J, Ge N.   +6 more
europepmc   +1 more source

Albuminuria as a diagnostic criterion and a therapeutic target in heart failure and other cardiovascular disease

European Journal of Heart Failure, EarlyView.
The value of uACR. CKD, chronic kidney disease; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; uACR, urine albumin‐to‐creatinine ratio. Abstract The high disease burden and bidirectional relationship of chronic kidney disease (CKD), heart failure (HF) and other cardiovascular disease (CVD) necessitate the need for early ...
Biykem Bozkurt, Patrick Rossignol, Joseph A. Vassalotti   +2 more
wiley   +1 more source

Coronary microvascular disease in heart failure with preserved ejection fraction. [PDF]

Physiol Rep
Sen P, Wang L, d'Ambrosio L, Bierschenk S, Hamers J, Ornek I, Sittig T, Zhang H, Zhang J, Merkus D.   +9 more
europepmc   +1 more source

Characterization of arrhythmia‐induced cardiomyopathy using magnetic resonance imaging in patients with persistent atrial fibrillation and left ventricular systolic dysfunction – insights from DECAAF II

European Journal of Heart Failure, EarlyView.
Arrhythmia‐induced cardiomyopathy (AIC) in left ventricular systolic dysfunction with atrial fibrillation (AF). HFrEF, heart failure with reduced ejection fraction; LVEF, left ventricular ejection fraction; MRI, magnetic resonance imaging. Abstract Aims Atrial fibrillation (AF) ablation in heart failure reduces mortality and hospitalizations and ...
Ala Assaf, Han Feng, Mayana Bsoul, Ghassan Bidaoui, Hadi Younes, Christian Massad, Mario Mekhael, Charbel Noujaim, Omar Kreidieh, Swati Rao, Amitabh Pandey, Philipp Sommer, Christian Mahnkopf, Nassir Marrouche, Christian Sohns   +14 more
wiley   +1 more source

The level of human epididymis protein 4 is associated with poor prognosis in patients with ejection fraction preserved heart failure. [PDF]

Front Cardiovasc Med
Tang Y, Chen Y, Huang XJ, Hu ZQ, Hu YJ, Peng SL, Pan HW.   +6 more
europepmc   +1 more source

Effect of pulmonary artery pressure‐guided management on outcomes of patients with heart failure outside clinical trials: A systematic review and meta‐analysis of real‐world evidence with the CardioMEMS Heart Failure System

European Journal of Heart Failure, EarlyView.
Meta‐analysis on the main outcomes of pulmonary artery pressure (PAP)‐guided management with the CardioMEMS Heart Failure (HF) System in patients with HF outside clinical trials. Effect measures are expressed as pooled means (95% CI), mean differences (95% CI), or pooled incidence rate ratios (95% CI), as appropriate.
Chris J. Kapelios, Sotiria Liori, Michael Bonios, William T. Abraham, Gerasimos Filippatos   +4 more
wiley   +1 more source